Simbionix

Simbionix

Until recently, surgeons gained most of their experience operating on people. Unusual anatomical structures or unexpected challenges sometimes became apparent only during the procedure, when the patient was on the operating table and time was of the essence.

Advances in simulation technology, including haptics and software, now make it possible for surgeons to practice and plan procedures in a simulated environment that looks and feels, to the surgeon, like a real procedure. Simbionix has emerged as the leader in the field of medical simulation and has, for three years running, outperformed both its sector and its competitors. The emerging use of Simbionix simulators for procedure planning has led to FDA Clearance for PROcedure Rehearsal Studio. This product enables medical device companies, like W.L. Gore, to launch new products with simulator technology for training, thus speeding customer training and adoption. 

Early Stage Partners has led multiple rounds of investment in Simbionix, the world leader in medical simulation technology for minimally-invasive surgery.

Recent Simbionix News

Simbionix Acquired By 3D Systems for $120 Million
Simbionix Launches Simulator Curriculum Management System
Medical Simulation Saves Lives in Battlefield Surgery
Simbionix Simulators Used to Practice in Advance of Surgery
W.L Gore Launches New Product Using PROcedure Rehearsal StudioSimbionix Receives Patent for PROcedure Rehearsal Studio
Simbionix Simulator Receives FDA Clearance
Simbionix Relocates Education Division to Cleveland
Simbionix Expands in U.S. and Israel
Simbionix Receives BIRD Grant to Develop Hysterectomy System
Simbionix Launches Mobile Application for Handheld Devices

 

 

 

Find Out More About ESP

Staff Photo

Jim Petras serves on the board of Simbionix.